首页> 外文期刊>Bone marrow transplantation >Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition.
【24h】

Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition.

机译:HSVtk转导的自杀淋巴细胞的产生和培养可诱导淋巴细胞亚群组成的变化。

获取原文
获取原文并翻译 | 示例
       

摘要

Allogeneic bone marrow transplant followed by donor lymphocyte infusion (DLI) is limited by T cell-mediated graft-versus-host disease (GVHD). A potential solution to alleviate uncontrolled GVHD is to create a controllable suicidal lymphocyte using retroviral transduction of the herpes simplex virus thymidine kinase gene (HSVtk) into the T cell graft. Should GVHD arise, the administration of ganciclovir (GCV) should eliminate the causal T cells. The culture conditions and expansion protocols required to produce suicidal lymphocytes may affect the composition of the T cell product. In this report we describe how T cells from individual donor samples respond to the same culture condition in highly varied ways. Among five donors, two demonstrated predominant expansion of CD4+ cells (with a decrease of CD8+), two donors resulted in predominately CD8+ cells, and one donor developed mainly dual positive CD8+/CD56+ cells. We observed a 20-fold expansion of T cells during the 14 day protocol. The function of the T cells was not affected by the transduction procedures (as tested by 51Cr release assays). In contrast to suicidal lymphocytes prepared using entire T cell populations, T cells pre-selected into CD3+/CD4+ or CD3+/CD8+ subpopulations prior to culture maintained their initial phenotype during the 14 day culture period, with little or no drift. Results from clinical trials using suicidal lymphocytes may be confounded by variance in lymphocyte subset compositions (LSC) and optimal use of suicidal lymphocytes may require separate culture and transduction to control the LSC delivered to the patient.
机译:T细胞介导的移植物抗宿主病(GVHD)限制了同种异体骨髓移植后再进行供体淋巴细胞输注(DLI)。缓解不受控制的GVHD的潜在解决方案是使用逆转录病毒将单纯疱疹病毒胸苷激酶基因(HSVtk)转导至T细胞移植物中,从而产生可控的自杀淋巴细胞。如果出现GVHD,更昔洛韦(GCV)的使用应消除因果性T细胞。产生自杀性淋巴细胞所需的培养条件和扩增方案可能会影响T细胞产物的组成。在本报告中,我们描述了来自各个供体样品的T细胞如何以多种多样的方式对相同的培养条件做出反应。在五个供体中,两个供体显示出CD4 +细胞显着扩增(CD8 +减少),两个供体产生了CD8 +细胞,而一个供体则发育出了双重阳性CD8 + / CD56 +细胞。我们在14天的方案中观察到了T细胞的20倍扩增。 T细胞的功能不受转导程序的影响(如51Cr释放试验所测试)。与使用完整T细胞群制备的自杀淋巴细胞相比,在培养前预选为CD3 + / CD4 +或CD3 + / CD8 +亚群的T细胞在14天培养期内保持其初始表型,几乎没有漂移。使用自杀性淋巴细胞的临床试验结果可能会因淋巴细胞亚群组成(LSC)的差异而混淆,自杀性淋巴细胞的最佳使用可能需要分开培养和转导,以控制输送给患者的LSC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号